The long-term effects of tibolone on aortic stiffness and endothelial function

References

• Newton JN. The epidemiology of coronary heart disease and HRT. What are the contentious issues? J Br Men Soc 1998;4:135–42
   Google Scholar
• Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prey Med 1991;20:47–63
   PubMed Web of Science ®Google Scholar
• Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453–61
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA 1998;280:605–13
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Stampfer MJ. Post-menopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. A prospective, observational study. Ann Intern Med 2001;135:1–8
   Google Scholar
• Women's Health Initiative. National Institutes of Health, National Heart, Lung and Blood Institute. www.nhlbi.nih.gov/whi/hrt-en. htn.2000. Ref Type: Electronic Citation
   Google Scholar
• Writing Group for the Women's Health Initia-tive Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal wo-men. JAMA 2002;288:321–33
   Google Scholar
• Media Statement — Discontinuation of the WISDOM study. www.mrc.ac.uk. 2002. Ref Type: Internet Communication
   Google Scholar
• The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Inter-ventions ( PEPI) Trial. JAMA 1995;273:199–208
   PubMed Web of Science ®Google Scholar
• van Baal WM, Kooistra T, Stehouwer CD. Cardiovascular disease risk and hormone repla-cement therapy (HRT): a review based on randomised, controlled studies in postmenopau-sal women. Curr Med Chem 2000;7:499–517
   Google Scholar
• McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmeno-pausal women: impact of hormone replacement therapy. Arterioscl Thromb Biol 1998;18:1149–56
   PubMed Web of Science ®Google Scholar
• Kelly RP, Hayward CS, Avolio AP, O'Rourke MF. Non-invasive determination of age related changes in the human arterial pulse. Circulation 1989;80:1652–9
   Google Scholar
• Cohn JN, Finkelstein S, McVeigh G, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995;26:503–8
   PubMed Web of Science ®Google Scholar
• Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Hypertension 1995;26:485–90
   PubMed Web of Science ®Google Scholar
• Marcus RH, Korcarz C, McCray G, et al. Noninvasive method for determination of arter-ial compliance using doppler echocardiography and subclavian pulse tracings. Validation and clinical application of a physiological model of the circulation. Circulation 1994;89:2688–99
   Google Scholar
• Millasseau SC, Guigui FG, Kelly RP, et al. Noninvasive assessment of the digital volume pulse: comparison with the peripheral pressure pulse. Hypertension 2000;36:952–6
   PubMed Web of Science ®Google Scholar
• Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG. Aortic compliance in young patients with heterozygous familial hypercholes-terolaemia . Clin Sci 1992;83: 717–21
   Google Scholar
• Hickler RB. Aortic and large artery stiffness: current methodology and clinical correlations. Clin Cardiol 1990;13:317–22
   PubMed Web of Science ®Google Scholar
• Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. London: Edward Arnold, 1990
   Google Scholar
• Rajkumar C, Kingwell BA, Cameron JD, et al. Hormone therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997;30:350–6
   PubMed Web of Science ®Google Scholar
• Liang YL, Teede H, Shiel LM, et al. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin Exp Pharmacol 1997;24:457–9
   Web of Science ®Google Scholar
• Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of atherosclerosis. Circulation 1991;83:391–401
   PubMed Web of Science ®Google Scholar
• Panza JA, Quyyumi AA, Brush JEJ, Epstein SE. Abnormal endothelium-dependent vascular re-laxation in patients with essential hypertension. N Engl J Med 1990;323:22–7
   PubMed Web of Science ®Google Scholar
• Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hyperten-sion. Circulation 1993;87:1468–74
   PubMed Web of Science ®Google Scholar
• Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hyperch-olesterolemic patients. J Clin Invest 1992;90: 1248–53
   PubMed Web of Science ®Google Scholar
• Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Role of nitric oxide in the endothelium-dependent vasodilation of hyperch-olesterolemic patients. Circulation 1993;88: 2541–7
   Google Scholar
• McVeigh GE, Brennan GM, Johnstone GD. Impaired endothelium-dependent and indepen-dent vasodilation with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1992;35: 771–6
   Google Scholar
• Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothe-fium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510–16
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to the coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468–74
   Google Scholar
• Kim-Schulze S, McGowan KA, Hubehak SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996;94:1402–7
   Google Scholar
• Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89:1943–50
   Google Scholar
• Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501–10
   Google Scholar
• Imthurn B, Rosselli M, Jager AW, Keller PJ, Dubey RK. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab 1997;82: 388–94
   Google Scholar
• Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilata-tion of human peripheral conduit arteries in vivo. Circulation 1995;91:1314–19
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunc-tion in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–15
   PubMed Web of Science ®Google Scholar
• Doshi SN, Lewis MJ, Goodfellow J. Improving endothelial vasomotor function may reduce cardiovascular risk, but the current evidence is circumstantial. Br Med J 2001;323:352–3
   Google Scholar
• Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936–41
   PubMed Web of Science ®Google Scholar
• Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol lowering therapies in hypercholesterolemic postmenopau-sal women. Circulation 1999;99:354–60
   PubMed Web of Science ®Google Scholar
• Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM. Individual and combined effects of estrogen/progestin therapy and lovas-tatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary heart disease. J Am Coll Cardiol 1999;33:2030–7
   Google Scholar
• Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234–8
   PubMed Web of Science ®Google Scholar
• Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Craven R, McGrath BP. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopau-sal women: effects on arterial compliance and endothelial function. Clin Endocrinol 2001; 55:673–82
   PubMed Web of Science ®Google Scholar
• Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symp-toms. Br J Obstet Gynaecol 1998;105:904–11
   Google Scholar
• Morris EP, Wilson PO, Robinson J, Rymer J. Long term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynae-col 1999;106:954–9
   PubMedGoogle Scholar
• Lehmann ED, Hopkins KD, Parker JR, et al. Aortic distensibility in post-menopausal women receiving tibolone. Br J Radiol 1994;67:701–5
   PubMed Web of Science ®Google Scholar
• de Kleijn MJ, Wilmink HW, Bots ML, et al. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Ather-osclerosis 2001;159:357–65
   Google Scholar
• Stadler RW, Karl WC, Lees RS. New methods for arterial diameter measurement from B-mode images. Ultrasound Med Biol 1996;22:25–34
   Google Scholar
• Stadler RW, Taylor JA, Lees RS. Comparison of B-mode, M-mode and echo-tracking methods for measurement of the arterial distension wave-form. Ultrasound Med Biol 1997;23:879–87
   Google Scholar
• Leeson P, Thorne S, Donald A, Mullen M, Clarkson P, Deanfield JE. Non-invasive mea-surement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997;78:22–7
   PubMed Web of Science ®Google Scholar
• Quan H, Shih WJ. Assessing reproducibility by the within-subject coefficient of variation with random effects models. Biometrics 1996;52: 1195–203
   PubMed Web of Science ®Google Scholar
• Simon JA, Hsia J, Cauley JA, et al. Postmeno-pausal hormone therapy and risk of stroke. The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001;103:638–42
   Google Scholar
• Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/ progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49–57
   Google Scholar
• Rymer JM. The effects of tibolone. Gynecol Endocrinol 1998;12:213–20
   PubMed Web of Science ®Google Scholar
• Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's character-istics. J Clin Epidemiol 1993;46:211–19
   Google Scholar
• Posthuma WFM, Westendorp RGJ, Vanden-broucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? Br Med J 1994;308: 1268–9
   Google Scholar
• Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN. Evidence of a healthy estrogen user survivor effect. Epidemiology 1995;6:207–8
   Google Scholar
• Haenggi W, Bersinger NA, Mueller MD, Bir-khaeuser MH. Decrease of serum endothelin levels with postmenopausal hormone replace-ment therapy or tibolone. Gynecol Endocrinol 1999;13:202–5
   Google Scholar
• Hardiman P, Nihoyannopoulos P, Kicovic P, Ginsburg J. Cardiovascular effects of Org 0D14 — a new steroidal therapy for climacteric symptoms. Maturitas 1991;13:235–42
   PubMed Web of Science ®Google Scholar
• Ceballos C, Ribes C, Amado JA, de Mier I, de Rozas LS, Berrazueta JR. Venous endothelial function in postmenopausal women after six months of tibolone therapy. Maturitas 2001; 39:63–70
   Google Scholar
• Lloyd GWL, Patel NR, McGing EA, Cooper AF, Kamalvand K, Jackson G. Acute effects of hormone replacement therapy with tibolone on myocardial ischaemia in women with angina. Int J Clin Pharmacol 1998;52:155–7
   Google Scholar
• Liang YL, Teede H, Kotsopoulos D, et al. Non-invasive measurements of arterial structure and function; repeatability, interrelationships and trial sample size. Clin Sci 1998;95:669–79
   PubMed Web of Science ®Google Scholar
• Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmeno-pausal women. Am J Med 1998;104:552–8
   PubMed Web of Science ®Google Scholar
• Mares P, Dauzat M, Abramovici Y, et al. Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women. Gynecol Obstet Fertil 2000;28:509–17
   PubMedGoogle Scholar
• Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Effect of medroxyprogesterone acetate on en-dothelium-dependent vasodilation in postmeno-pausal women receiving estrogen. Circulation 2001;104:1773–8
   PubMed Web of Science ®Google Scholar